These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Emerging science, emerging ethical issues: who should fund innate alloimmunity-suppressing drugs? Land WG; Gutmann T; Daar AS Acta Chir Belg; 2008; 108(1):73-82. PubMed ID: 18411578 [TBL] [Abstract][Full Text] [Related]
23. Policy statement on the social, ethical and public awareness issues in gene therapy. Gänsbacher B J Gene Med; 2002; 4(6):687-91. PubMed ID: 12439860 [No Abstract] [Full Text] [Related]
24. Health-related biotechnologies for infectious disease control in Africa: Ethical, Legal and Social Implications (ELSI) of transfer and development. Sommerfeld J; Oduola AM Afr J Med Med Sci; 2007; 36 Suppl():1-5. PubMed ID: 17703556 [TBL] [Abstract][Full Text] [Related]
25. Genetics in dental practice: social and ethical issues surrounding genetic testing. Gettig E; Hart TC J Dent Educ; 2003 May; 67(5):549-62. PubMed ID: 12809190 [TBL] [Abstract][Full Text] [Related]
26. Business Ethics 101 for the biotech industry. MacDonald C BioDrugs; 2004; 18(2):71-7. PubMed ID: 15046523 [TBL] [Abstract][Full Text] [Related]
27. Attitudes of the public and scientists to biotechnology in Japan at the start of 2000. Ng MA; Takeda C; Watanabe T; Macer D Eubios J Asian Int Bioeth; 2000 Jul; 10(4):106-13. PubMed ID: 16273712 [TBL] [Abstract][Full Text] [Related]
28. Gene therapy legislation in The Netherlands. Bleijs DA; Haenen IT; Bergmans JE J Gene Med; 2007 Oct; 9(10):904-9. PubMed ID: 17721872 [TBL] [Abstract][Full Text] [Related]
29. Provision of genetic services in Europe: current practices and issues. Godard B; Kääriäinen H; Kristoffersson U; Tranebjaerg L; Coviello D; Aymé S Eur J Hum Genet; 2003 Dec; 11 Suppl 2():S13-48. PubMed ID: 14718937 [TBL] [Abstract][Full Text] [Related]
30. Mapping the integration of social and ethical issues in health technology assessment. Lehoux P; Williams-Jones B Int J Technol Assess Health Care; 2007; 23(1):9-16. PubMed ID: 17234011 [TBL] [Abstract][Full Text] [Related]
31. Biopharmaceuticals in China. Hu X; Ma Q; Zhang S Biotechnol J; 2006 Nov; 1(11):1215-24. PubMed ID: 17089435 [TBL] [Abstract][Full Text] [Related]
32. ASAS Centennial Paper: Developments and future outlook for preharvest food safety. Oliver SP; Patel DA; Callaway TR; Torrence ME J Anim Sci; 2009 Jan; 87(1):419-37. PubMed ID: 18708597 [TBL] [Abstract][Full Text] [Related]
33. Gene therapy progress and prospects: bringing gene therapy into medical practice: the evolution of international ethics and the regulatory environment. Spink J; Geddes D Gene Ther; 2004 Nov; 11(22):1611-6. PubMed ID: 15385950 [TBL] [Abstract][Full Text] [Related]
34. Family pediatrics: report of the Task Force on the Family. Schor EL; Pediatrics; 2003 Jun; 111(6 Pt 2):1541-71. PubMed ID: 12777595 [TBL] [Abstract][Full Text] [Related]
36. Genetic information and testing in insurance and employment: technical, social and ethical issues. Godard B; Raeburn S; Pembrey M; Bobrow M; Farndon P; Aymé S Eur J Hum Genet; 2003 Dec; 11 Suppl 2():S123-42. PubMed ID: 14718940 [TBL] [Abstract][Full Text] [Related]
37. Regulation of clinical research and bioethics in Portugal. Carvalho FL Bioethics; 2007 Jun; 21(5):290-302. PubMed ID: 17845474 [TBL] [Abstract][Full Text] [Related]
38. [Ethical guidelines on genetic testing and gene therapy]. Fukushima Y Nihon Rinsho; 2005 Mar; 63(3):389-93. PubMed ID: 15773335 [TBL] [Abstract][Full Text] [Related]
39. Indian Biotech Bazaar: a swot analysis. Kumar A Biotechnol J; 2007 May; 2(5):543-5. PubMed ID: 17479978 [TBL] [Abstract][Full Text] [Related]
40. Use of animals in experimental research: an ethical dilemma? Baumans V Gene Ther; 2004 Oct; 11 Suppl 1():S64-6. PubMed ID: 15454959 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]